229 -Outsourcing Analytical Testing: What Sponsors Get Wrong in Combination Products

Let's Combinate · 11 Mar 2026 · 31m

What this episode covers

Jen Riter, an analytical testing leader with experience at West Pharmaceutical Services and Kindeva Drug Delivery, explains the critical differences between validating chemical methods under ICH Q2 and functional/mechanical methods for combination products. She details the necessity of using an engineering mindset, including Measurement System Analysis (MSA) and gage R&R, and the use of fabricated surrogate standards like metal syringes to validate performance methods. The discussion covers leveraging ISO 11040 for platform methods, the verification versus validation debate between ISO and USP standards, and strategic decisions regarding outsourcing specialized testing such as Container Closure Integrity Testing (CCIT) and extractables/leachables to contract laboratories.

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 35m

    #467: Combination Product Compliance: PMOA, 21 CFR Part 4 & QMS Alignment

    Jim Fentress, Director of Regulatory Affairs at Galero (a Santa Group company), explains the regulatory complexities of combination products, focusing on how the Primary Mode of Action (PMOA) dictates FDA oversight. He details the challenges pharmaceutical companies face when integrating device Quality Management Systems (QMSR/ISO 13485) into their existing CGMP frameworks under 21 CFR Part 4. The discussion covers specific friction points like risk management alignment (AAMI TIR105 vs. ICH Q9), labeling classifications, and the critical need for transparent change control protocols between device manufacturers and pharma partners.

  • Global Medical Device Podcast · 42m

    How to Select a Contract Manufacturer

    Mark Rutkiewicz, VP of Quality at Innovize and founder of Consiliso LLC, explains how medical device companies should select and manage contract manufacturers (CMs). He emphasizes the importance of supplier quality agreements, risk-based criticality levels, and the use of MedAccred for auditing. The discussion covers the trade-offs between manual and automated processes, the necessity of master validation plans, and the need for transparent communication regarding patient impact and product usage.

  • Global Medical Device Podcast · 41m

    Quality Management for IVD Devices vs Medical Devices

    Joanne LeBrun of MDC Associates explains that while In Vitro Diagnostic (IVD) devices share quality management system (QMS) requirements with medical devices, they differ in performance proof, with IVDs often relying on leftover specimens rather than clinical studies. She highlights that the EU IVDR has significantly expanded regulation by changing device classification, while the pandemic has accelerated startup growth through contract manufacturing and molecular science advancements. LeBrun advises startups to avoid starting with a blank QMS, emphasizing the importance of robust internal audits, real-time documentation, and managing FDA inspections to prevent costly field failures and recalls.

  • Global Medical Device Podcast · 58m

    #392: Verification and Validation in MedTech: A Practical Guide with Devon Campbell

    Devon Campbell, a medical device consultant, explains the critical distinctions between verification (did we build the product right?) and validation (did we build the right product?) for early-stage medtech companies. He emphasizes that strong, testable user needs and design inputs are prerequisites for successful V&V, warning that weak requirements lead to validation failures. Campbell advocates for pre-verification testing to refine protocols and manage sample sizes, ensuring that design reviews and traceability are robust before formal regulatory submission.

  • Global Medical Device Podcast · 44m

    #384: Insights from an Ex-FDA Investigator: Compliance, Quality Systems, and MedTech Trends

    Vincent Cafiso, Director of Quality and Regulatory Services at Creo Consulting and former FDA investigator, discusses the critical need for MedTech companies to align R&D testing environments with production standards to avoid costly rework and data rejection. He highlights common pitfalls in design controls, such as missing real-time aging data and inadequate documentation in Design History Files, urging companies to integrate quality validation early in the development process. Cafiso also emphasizes the importance of management responsibility and breaking down organizational silos through skip-level meetings to maintain a collaborative, startup-like culture as companies scale from garage startups to enterprise levels.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.